Clinical Trials Directory

Trials / Completed

CompletedNCT01860547

Effects of Berries and Berry Fractions on Metabolic Diseases

The Effect of the Bioactives of Sea Buckthorn and Bilberry on the Risk of Metabolic Diseases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
University of Turku · Academic / Other
Sex
Female
Age
30 Years – 55 Years
Healthy volunteers
Accepted

Summary

The study hypothesis is that the bioactive compounds of sea buckthorn berries (Hippophaë rhamnoides), their fractions, and bilberries (Vaccinium myrtillus). have positive effects on lipid and carbohydrate metabolism and will thus reduce the risk of developing metabolic diseases.

Detailed description

The aim of the project was to investigate whether it is possible to reduce the risk of metabolic diseases with supplementing the diet with sea buckthorn berries (Hippophaë rhamnoides), their bioactive fractions, and bilberries (Vaccinium myrtillus). The study design was a randomized cross-over clinical trial. The participants were slightly and moderately overweight female subjects. In total, 110 female volunteers were recruited, and they followed four different berry diets (bilberry, sea buckthorn, sea buckthorn phenolic extract and sea buckthorn oil) in a randomized order for 33-35 days. Each intervention was followed by a wash-out period of 30-39 days. Blood samples were drawn and physical measurements were performed after each period. Eighty volunteers completed the study. Different markers of lipid and carbohydrate metabolism and inflammation were measured form the blood samples.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBilberriesFrozen bilberries, 100 g/d
DIETARY_SUPPLEMENTSea buckthorn berryDried sea buckthorn berries, 20 g/d
DIETARY_SUPPLEMENTSea buckthorn phenolic extractEthanol-water extract from sea buckthorn berries, combined with maltodextrin, 14.6 g/d (7.3 g sea buckthorn extract + 7.3 g maltodextrin)
DIETARY_SUPPLEMENTSea buckthorn oilSea buckthorn oil, 4 g (8 capsules)/d

Timeline

Start date
2008-06-01
Primary completion
2009-06-01
Completion
2009-08-01
First posted
2013-05-22
Last updated
2013-05-22

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01860547. Inclusion in this directory is not an endorsement.